Back to Search Start Over

The mitochondrial mRNA-stabilizing protein SLIRP regulates skeletal muscle mitochondrial structure and respiration by exercise-recoverable mechanisms.

Authors :
Pham TCP
Raun SH
Havula E
Henriquez-Olguín C
Rubalcava-Gracia D
Frank E
Fritzen AM
Jannig PR
Andersen NR
Kruse R
Ali MS
Irazoki A
Halling JF
Ringholm S
Needham EJ
Hansen S
Lemminger AK
Schjerling P
Petersen MH
de Almeida ME
Jensen TE
Kiens B
Hostrup M
Larsen S
Ørtenblad N
Højlund K
Kjær M
Ruas JL
Trifunovic A
Wojtaszewski JFP
Nielsen J
Qvortrup K
Pilegaard H
Richter EA
Sylow L
Source :
Nature communications [Nat Commun] 2024 Nov 13; Vol. 15 (1), pp. 9826. Date of Electronic Publication: 2024 Nov 13.
Publication Year :
2024

Abstract

Decline in mitochondrial function is linked to decreased muscle mass and strength in conditions like sarcopenia and type 2 diabetes. Despite therapeutic opportunities, there is limited and equivocal data regarding molecular cues controlling muscle mitochondrial plasticity. Here we uncovered that the mitochondrial mRNA-stabilizing protein SLIRP, in complex with LRPPRC, is a PGC-1α target that regulates mitochondrial structure, respiration, and mtDNA-encoded-mRNA pools in skeletal muscle. Exercise training effectively counteracts mitochondrial defects caused by genetically-induced LRPPRC/SLIRP loss, despite sustained low mtDNA-encoded-mRNA pools, by increasing mitoribosome translation capacity and mitochondrial quality control. In humans, exercise training robustly increases muscle SLIRP and LRPPRC protein across exercise modalities and sexes, yet less prominently in individuals with type 2 diabetes. SLIRP muscle loss reduces Drosophila lifespan. Our data points to a mechanism of post-transcriptional mitochondrial regulation in muscle via mitochondrial mRNA stabilization, offering insights into how exercise enhances mitoribosome capacity and mitochondrial quality control to alleviate defects.<br />Competing Interests: Competing interests Since the study concluded, Solvejg Hansen, Jens Frey Halling and Anders Krogh Lemminger have become employees and shareholders of Novo Nordisk A/S, Denmark. The remaining authors declare no competing interests.<br /> (© 2024. The Author(s).)

Details

Language :
English
ISSN :
2041-1723
Volume :
15
Issue :
1
Database :
MEDLINE
Journal :
Nature communications
Publication Type :
Academic Journal
Accession number :
39537626
Full Text :
https://doi.org/10.1038/s41467-024-54183-4